TriSalus Life Sciences
$0.9285
2
+$0.03+3.17% Thursday 19:48
Statistics
Day High
0.88
Day Low
0.87
52W High
2.19
52W Low
0.441
Volume
384
Avg. Volume
3,641
Mkt Cap
57.17M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.96
-0.63
-0.3
0.03
Expected EPS
-0.12388
Actual EPS
N/A
Financials
-341.83%Profit Margin
Unprofitable18.51MRevenue
-63.28MNet Income
Analyst Ratings
7.50Average Price Target
The highest estimate is 8.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
Show more...
CEO
Mary T. Szela
Employees
102
Country
United States
ISIN
US89680M1190
Listings
0 Comments
Share your thoughts
FAQ
What is TriSalus Life Sciences stock price today?▼
The current price of TLSIW is $0.93 USD — it has increased by +3.17% in the past 24 hours. Watch TriSalus Life Sciences stock price performance more closely on the chart.
What is TriSalus Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange TriSalus Life Sciences stocks are traded under the ticker TLSIW.
Is TriSalus Life Sciences stock price growing?▼
TLSIW stock has risen by +3.17% compared to the previous week, the month change is a +7.34% rise, over the last year TriSalus Life Sciences has showed a -43.73% decrease.
What is TriSalus Life Sciences market cap?▼
Today TriSalus Life Sciences has the market capitalization of 57.17M
When is the next TriSalus Life Sciences earnings date?▼
TriSalus Life Sciences is going to release the next earnings report on November 12, 2026.
What were TriSalus Life Sciences earnings last quarter?▼
TLSIW earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.16 USD resulting in a -3.23% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is TriSalus Life Sciences revenue for the last year?▼
TriSalus Life Sciences revenue for the last year amounts to 18.51M USD.
What is TriSalus Life Sciences net income for the last year?▼
TLSIW net income for the last year is -63.28M USD.
How many employees does TriSalus Life Sciences have?▼
As of September 04, 2026, the company has 102 employees.
In which sector is TriSalus Life Sciences located?▼
TriSalus Life Sciences operates in the Health & Wellness sector.
When did TriSalus Life Sciences complete a stock split?▼
TriSalus Life Sciences has not had any recent stock splits.
Where is TriSalus Life Sciences headquartered?▼
TriSalus Life Sciences is headquartered in WESTMINSTER, United States.